期刊文献+

嗜麦芽窄食单胞菌感染的临床分布和耐药性分析 被引量:5

Analysis of clinical distribution and drug resistance of Stenotrophomonas maltophilia infection
原文传递
导出
摘要 目的了解医院嗜麦芽窄食单胞菌感染的临床分布及耐药情况,为医院感染控制及临床用药提供指导。方法回顾性分析本院2012年1月-2014年12月1 067株嗜麦芽窄食单胞菌的标本来源、科室分布及药敏结果。结果菌株主要来源于呼吸道标本,占89.69%,其次为分泌物、胆汁,所占比例分别为3.19%、2.91%;菌株临床分布主要为ICU、神经外科病区,所占比例分别为45.92%、16.03%;该菌对米诺环素最敏感,3年耐药率为0.00%~1.42%,对甲氧苄啶-磺胺甲噁唑和左氧氟沙星的耐药率均〈20%,对头孢哌酮/舒巴坦的耐药率为8.16%~8.60%。结论嗜麦芽窄食单胞菌主要分离自ICU及神经外科以痰为主的呼吸道标本。该菌对CLSI推荐的药物耐药率均较低(〈20%),抗菌活性3年基本保持稳定,应根据药敏结果合理选用抗菌药物进行治疗。 Objective To understand the clinical distribution characters and drug resistance of Stenotrophomonas maltophilia infetion so as to guide the rational usage of clinical drugs and control the infection. Methods From 2012 January to 2014 December,a total of 1 067 strains of Stenotrophomonas maltophilia were retrospectively analyzed of specimen source,distribution of departments and the drug sensitivity results. Results Stenotrophomonas maltophilia isolated from this hospital were mainly respiratory specimens,accounting for 89. 69%,the following were secretion and bile,accounting for 3. 19% and 2. 91%,respectively; the strains were mainly distributed at intensive care unit( ICU) and department of neurosurgery,accounting for 45. 92% and16. 03%,respectively; the bacteria were most sensitive to minocycline,the resistance rate for 3 years was 0. 00%- 1. 42%;the resistance rate to trimethoprim sulphamethoxazole and trimethoprim and levofloxacin rate was less than 20%,and the resistance rate to cefoperazone / sulbactam was 8. 16%- 8. 60%. Conclusion Stenotrophomonas maltophilia mainly isolated from sputum of ICU and department of neurosurgery and respiratory specimens. The resistance rate of the bacteria were low of the drug which recommended by CLSI( 20%); the antibacterial activity were remained stability in three years. According to the results of drug sensitivity,antibiotics should be rationally selected for treatment.
作者 施新颜 沈强
出处 《中国卫生检验杂志》 CAS 2015年第15期2626-2628,共3页 Chinese Journal of Health Laboratory Technology
关键词 嗜麦芽窄食单胞菌 临床分布 抗菌药物 Stenotrophomonas maltophilia Clinical distribution Antibiotics
  • 相关文献

参考文献5

  • 1艾效曼,胡云建,俞云松,杨青,倪语星,孙景勇,徐英春,张小江,孙自镛,陈中举,汪复,朱德妹,胡付品,卓超,苏丹虹,徐元宏,沈继录,单斌,杜艳,魏莲花,吴玲,张朝霞,季萍,王传清,王爱敏,贾蓓,黄文祥,张泓,孔菁.2010年中国CHINET嗜麦芽窄食单胞菌耐药性监测[J].中国感染与化疗杂志,2012,12(2):105-109. 被引量:37
  • 2汪道峰,娄宁.重症肿瘤患者嗜麦芽寡养单胞菌肺部感染危险因素分析[J].中华医院感染学杂志,2014,24(6):1394-1396. 被引量:12
  • 3蔡国宁,周卓清.ICU内嗜麦芽窄食单胞菌肺部感染的临床分析[J].中国全科医学,2010,25(5):357-359.
  • 4艾效曼,胡云建,俞云松,杨青,倪语星,孙景勇,徐英春,张小江,孙自镛,陈中举,汪复,朱德妹,胡付品,卓超,苏丹虹,徐元宏,沈继录,单斌,杜艳,魏莲花,吴玲,张朝霞,季萍,王传清,王爱敏,贾蓓,黄文祥,张泓,孔菁.2011年中国CHINET嗜麦芽窄食单胞菌耐药性监测[J].中国感染与化疗杂志,2014,14(2):94-99. 被引量:20
  • 5Abbott LJ, Slavin MA, Tumidge JD, et al. Stenotrophomonas mnl- tophilia:emerging disease patterns and challenges for treatment. Ex- pert Rev[J]. Anti Infect Ther, 2011,9(4) : 471 -488.

二级参考文献27

  • 1汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 2Clinical and Laboratory Standards Institute(CLSI)/NCCLS. Performance Standards for Antimicrobial Susceptibility tes ting Standards twentyth Informational Supplement [S]. 2010, M100-s20.
  • 3National Committee for Clinical Laboratory Stardards. Per- formance standards for antimicrobial susceptibility testing [s]. Fourteenth Informational Supplement 2004, M100 s14, 24: 36-38.
  • 4Yao JD, Louie M,Louie L, et al. Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas(Xanthomonas) maltophilia[J]. J Clin M icrobio, 1995, 33(5) .. 1428-1430.
  • 5Barry AL, Jones RN. Criteria for Disk Susceptibility tests and quality control guidelines for the cefoperazone-sulbactam Combination[J]. Clin Microbiol, 1988,26(1) :13-17.
  • 6Liu YM, Chen YS, Toh HS, et al.In vitro susceptibilities of non Enterobacteriaceae isolates from patients with intra.-ab dominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)[J]. Int J Antimicrob Agents, 2012, 40 Suppl:s11- s17.
  • 7Brooke JS. Stenotrophornonas maltophilia: an emerging global opportunistic palhogen [J ]. Clin Microbiol Rev, 2012, 25 (1): 2 -41.
  • 8Clinical and Laboratory Standards Institute (CI.SI)/ NCCI.S. Performance Standards for Antimicrobial Susceptibility tes ring Standards: twentyth Informational Supplement [S]. 2011, M100 -S21.
  • 9Abbott U, Slavin MA, Turnidge JD, et al. Stenotrophomonas ma ltophilia : emerging disease patterns and challenges for treat ment. Expert Rev[J]. Anti Infect Ther, 2011, 9(4): 471 -488.
  • 10(;hung HS, Hong SG, Kim YR, et al. Antimicrobial suscep tibility of Stenotrophomonas maltophilia isolates from Korea and the activity of antimicrobial combinations against the iso lates[J]. J Korean Med Sci,2013,28(1):62- 66.

共引文献65

同被引文献40

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部